Skip to search boxSkip to navigationSkip to main content

New tyrosine kinase inhibitors in chronic myeloid leukemia (CML)

  • H. Kantarjian(corresponding author)
    ,
  • J. Cortes
*Corresponding author for this work
  • University of Texas MD Anderson Cancer Center
Scholary Output:
Contribution to journal
Article
 Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
 Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages S16-S19

Journal (Volume, Issue Number)

Leukemia Research (Volume 31, Issue SUPPL. 2)

Publication milestones

  • Published - 09/2007

Publication status

Published - 09/2007

ISSN

0145-2126

Publication IDs

  • Scopus: 36049049350
  • ORCID: /0000-0002-8636-1071/work/68887862

Access to documents

Publication metrics

Metrics

Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1
SciVal
Author count
2
SciVal
Paper percentile
25